Therapeutic Efficacy of Oral L-Ornithine-L-Aspartate on Minimal Encephalopathy
NCT00896831
·
clinicaltrials.gov ↗
PHASE4
Phase
UNKNOWN
Status
96
Enrollment
OTHER
Sponsor class
Conditions
Hepatic Encephalopathy
Interventions
DRUG:
L-ornithine-L-aspartate
DRUG:
placebo
Sponsor
Hospital de Clinicas de Porto Alegre